Stomach cancer history and symptoms: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
| Line 36: | Line 36: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Gastroenterology]] | |||
[[Category:Surgery]] | |||
Revision as of 16:57, 27 November 2017
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
|
Stomach cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Stomach cancer history and symptoms On the Web |
|
American Roentgen Ray Society Images of Stomach cancer history and symptoms |
|
Risk calculators and risk factors for Stomach cancer history and symptoms |
Overview
Symptoms of stomach cancer include abdominal pain, bloating, weight loss, hematemesis and melena.
Symptoms
- Stomach cancer is often asymptomatic or causes only nonspecific symptoms in its early stages.
- By the time symptoms occur, the cancer has generally metastasized to other parts of the body, one of the main reasons for its poor prognosis.
- Stomach cancer can cause the following signs and symptoms:
History
- Twenty-five percent of patients have a history of gastric ulcer.
Common symptoms[1][2]
- Weight loss: due to insufficient caloric intake, early satiety, and dysphagia
Less common symptoms[1]
- Abdominal pain or discomfort in the upper abdomen, tends to be epigastric and mild
- Nausea and vomiting: : may be due to the mass itself or gastric outlet obstruction from an advanced distal tumor
- Weakness and fatigue
- Hematemesis and melena: occult bleeding accompanied with iron deficiency anemia, overt bleeding is seen in less than 20% of cases.
- Dysphagia in proximal masses
References
- ↑ 1.0 1.1 Siegel RL, Miller KD, Jemal A (2016). "Cancer statistics, 2016". CA Cancer J Clin. 66 (1): 7–30. doi:10.3322/caac.21332. PMID 26742998.
- ↑ 2.0 2.1 Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C; et al. (2013). "Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines". J Natl Compr Canc Netw. 11 (5): 531–46. PMID 23667204.